These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 31809275)
1. Retiform Purpura as a Complication of Microsphere Emboli Following Transarterial Chemoembolization for Primary Hepatocellular Carcinoma: A Case Report and Literature Review. Kuan A; Khoo L; Yang SS; Chia HY; Lee JSS Am J Dermatopathol; 2020 Jul; 42(7):e108-e110. PubMed ID: 31809275 [TBL] [Abstract][Full Text] [Related]
2. Retiform Purpura After Transcatheter Arterial Chemoembolization: A Case Report. Hansen T; Olsen K; White K; Keller J Am J Dermatopathol; 2018 Feb; 40(2):e25-e27. PubMed ID: 28700373 [TBL] [Abstract][Full Text] [Related]
3. Conventional transarterial chemoembolization vs microsphere embolization in hepatocellular carcinoma: a meta-analysis. Ni JY; Xu LF; Wang WD; Sun HL; Chen YT World J Gastroenterol; 2014 Dec; 20(45):17206-17. PubMed ID: 25493037 [TBL] [Abstract][Full Text] [Related]
4. Embolization of the hepatic falciform artery to prevent supraumbilical skin rash during transcatheter arterial chemoembolization for hepatocellular carcinoma. Ueno K; Miyazono N; Inoue H; Miyake S; Nishida H; Nakajo M Cardiovasc Intervent Radiol; 1995; 18(3):183-5. PubMed ID: 7648596 [TBL] [Abstract][Full Text] [Related]
5. Drug-Eluting Microsphere Versus Cisplatin-Based Transarterial Chemoembolization for the Treatment of Hepatocellular Carcinoma: Propensity Score-Matched Analysis. Chu HH; Gwon DI; Kim JH; Ko GY; Shin JH; Yoon HK AJR Am J Roentgenol; 2020 Sep; 215(3):745-752. PubMed ID: 32569514 [No Abstract] [Full Text] [Related]
6. Supraumbilical skin rash and fat necrosis after transcatheter arterial chemoembolization: a case report. Lin CC; Wu DK; Shih PM; Liu GC; Chuang WL Kaohsiung J Med Sci; 2004 Jan; 20(1):36-40. PubMed ID: 15481565 [TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease. Fidelman N; Kerlan RK AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322 [TBL] [Abstract][Full Text] [Related]
8. Liver chemoembolization of hepatocellular carcinoma using TANDEM Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255 [TBL] [Abstract][Full Text] [Related]
10. [Ischemic gastroduodenal ulcer as a complication of hepatic hepatocarcinoma transarterial chemoembolization]. de Zárraga Mata C; Thomás Salom G; Maura Oliver ÁL Rev Gastroenterol Peru; 2019; 39(4):367-369. PubMed ID: 32097399 [TBL] [Abstract][Full Text] [Related]
11. Biloma following transcatheter arterial chemoembolization with microspheres: a case report. Huang CK; Chen SC; Shih PM; Chuang WL Kaohsiung J Med Sci; 2007 Sep; 23(9):470-4. PubMed ID: 17766216 [TBL] [Abstract][Full Text] [Related]
12. Update on Transarterial Chemoembolization with Drug-Eluting Microspheres for Hepatocellular Carcinoma. Nouri YM; Kim JH; Yoon HK; Ko HK; Shin JH; Gwon DI Korean J Radiol; 2019 Jan; 20(1):34-49. PubMed ID: 30627020 [TBL] [Abstract][Full Text] [Related]
13. Risk Factors for the Development of Postembolization Syndrome after Transarterial Chemoembolization for Hepatocellular Carcinoma Treatment. Lima M; Dutra S; Gomes FV; Bilhim T; Coimbra É Acta Med Port; 2018 Jan; 31(1):22-29. PubMed ID: 29573765 [TBL] [Abstract][Full Text] [Related]
14. An unusual complication following transarterial chemoembolization: acute myocardial infarction. Lai YL; Chang WC; Kuo WH; Huang TY; Chu HC; Hsieh TY; Chang WK Cardiovasc Intervent Radiol; 2010 Feb; 33(1):196-200. PubMed ID: 19730938 [TBL] [Abstract][Full Text] [Related]
15. Transarterial chemoembolization for hepatocellular carcinoma: An old method, now flavor of the day. Boulin M; Delhom E; Pierredon-Foulongne MA; Cercueil JP; Guiu B Diagn Interv Imaging; 2015 Jun; 96(6):607-15. PubMed ID: 25998996 [TBL] [Abstract][Full Text] [Related]
16. Dexrazoxane prevents skin necrosis in non-target embolization of falciform artery during transcatheter arterial chemoembolization (TACE). Stalder G; Deplanque G; Shabafrouz K; Orcurto A; Bize P; Duran R; Denys A Diagn Interv Imaging; 2018 Mar; 99(3):179-180. PubMed ID: 29033238 [No Abstract] [Full Text] [Related]
17. Transarterial chemoembolization with DC Bead LUMI™ radiopaque beads for primary liver cancer treatment: preliminary experience. Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Cillo U; Guadagni S; Fiorentini G Future Oncol; 2017 Oct; 13(25):2243-2252. PubMed ID: 29063780 [TBL] [Abstract][Full Text] [Related]
18. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study. Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418 [TBL] [Abstract][Full Text] [Related]
19. [Extrahepatic collateral arteries are involved in the blood supply to hepatocellular carcinoma: angiographic demonstration and transcatheter arterial chemoembolization]. Li Q; Yang RJ; Zhu X; Zhu LZ; Wang MQ; Duan F Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):613-7. PubMed ID: 24314221 [TBL] [Abstract][Full Text] [Related]
20. [Analysis of clinical prognosis and the correlation between bile duct injury after transcatheter arterial chemoembolization and the level of hepatic arterial embolization in patients with hepatocellular carcinoma]. Xu HY; Yu XP; Feng R; Hu HJ; Xiao WW Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):355-360. PubMed ID: 28535652 [No Abstract] [Full Text] [Related] [Next] [New Search]